October 11, 2022
Meet Surbhi Shah, M.B.B.S., M.D. – Driven to learn, incorporating learning to improve care
By Advancing the Science contributor
Surbhi Shah, M.B.B.S., M.D., is a hematologist at Mayo Clinic in Arizona., whose focus is on treating patients with non-cancerous blood disorders. In addition to her clinical duties, Dr. Shah dedicates time both to learning, and to sharing what she learns – through teaching, mentoring, presentation and publication. To expand her own understanding and increase Mayo’s […]
Tags: anticoagulant, blood disease, Center for the Science of Health Care Delivery, clinical research, Fadi Shamoun, hematology, hemophilia, Jennifer Ridgeway, Kern Health Care Delivery Scholars, learning health system, medical innovation, mentorship
March 2, 2022
Research News Roundup — January, February 2022
By Advancing the Science contributor
At Mayo Clinic, researchers work across the spectrum of health care and disease, from basic discovery science to transformations in patient care. They translate early findings into therapeutic or preventive interventions via clinical research and innovative pilot projects. Mayo Clinic researchers publish thousands of articles in peer-reviewed journals each year. A fraction of those findings […]
Tags: A. Noelle Larson, Andrew Bentall, animal model, anticoagulant, biomedical engineering, bone regeneration, cardiovascular disease, chemotherapy, cirrhosis, COVID-19, gastrointestinal cancer, health disparities
August 5, 2019
Blood thinners in combination increase bleeding risk, Mayo study finds
Gastrointestinal bleeding is a common side effect for many blood-thinning medications. But new Mayo Clinic research finds that risk is amplified when patients receive more than one blood thinner – especially if they’re 75 or older. The study, published in Clinical Gastroenterology and Hepatology, found patients receiving an anticoagulant drug and an antiplatelet drug, in […]
Tags: AHRQ, anticoagulant, antiplatelet, blood thinner, Center for the Science of Health Care Delivery, Che Ngufor, gastroenterology, Neena Abraham, Nilay Shah, OptumLabs, Peter Noseworthy, Xiaoxi Yao
May 3, 2018
Using new data to personalize stroke prevention
By Advancing the Science contributor
By Peter Noseworthy, MD, with Xiaoxi Yao, PhD, Mayo Clinic The irregular heartbeat known as atrial fibrillation (AF) is a common and serious heart disease impacting about 3 million Americans today. Patients with AF experience palpitations, shortness of breath and dizziness, which can make simple activities such as playing with grandchildren or walking upstairs challenging. […]
Tags: anticoagulant, atrial fibrillation, Center for the Science of Health Care Delivery, OptumLabs, Peter Noseworthy, Xiaoxi Yao
December 6, 2017
Research Roundup–November 2017
The Research Roundup is a compilation of research news releases from Mayo Clinic during the last month. You can read the brief summaries in this post, or click through for the full news release and related content. Thanks for visiting Advancing the Science! Research finds hot flashes, night sweats connected to obstructive sleep apnea risk […]
Tags: anticoagulant, atrial fibrillation, cardiology, Center for Individualized Medicine, clinical trials, J. William Charboneau, Joseph Grande, menopause, MOG antibody, neurology, prostate cancer, research education
August 2, 2017
Mayo researchers to explore safety of combining blood-thinners
Millions of Americans are taking blood-thinning drugs for common medical conditions. Often, they receive prescriptions for more than one when they have multiple chronic diseases or conditions. As Americans age and the number of people on these drugs is expected to steadily increase over the coming decades, researchers are trying to better understand how the […]
Tags: anticoagulant, Center for the Science of Health Care Delivery, gastroenterology, Neena Abraham
June 19, 2017
1 in 6 taking blood-thinning drugs may not be getting right dose, research shows
A growing number of Americans are expected to develop atrial fibrillation, a common heart condition characterized by an irregular and rapid heart rate. But almost 1 in 6 of the millions of Americans on new blood-thinning medications for a-fib may not be getting the right dose, Mayo Clinic research finds.
Tags: anticoagulant, atrial fibrillation, Center for the Science of Health Care Delivery, kidney disease, OptumLabs, Peter Noseworthy, stroke, Xiaoxi Yao
May 3, 2016
Determining which drug works better for which patients “Our findings definitely point toward important age-related risk that merits consideration when doctors are making treatment recommendations,” says lead author Neena Abraham, M.D. To the average TV viewer, it may seem like new drugs flood the marketplace daily. However, from the 1950s until just recently, warfarin was […]
Tags: anticoagulant, atrial fibrillation, cardiology, Center for the Science of Health Care Delivery, FDA, Neena Abraham
January 5, 2016
Did your patient have cardiac ablation? Don’t stop the anticoagulant!
By Advancing the Science contributor
Peter Noseworthy, M.D., is a cardiac electrophysiologist at Mayo Clinic, and a Kern Health Care Delivery Scholar in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. ________________________________________________________________________ As a cardiac electrophysiologist, I am interested in helping to improve health and quality of life for my patients […]
Tags: anticoagulant, atrial fibrillation, cardiology, Center for the Science of Health Care Delivery, OptumLabs, Peter Noseworthy, stroke
May 29, 2015
Precision Medicine Using Big Data
One of our goals at Mayo Clinic is to improve the way patients experience health care. We established the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery to investigate ways to improve across the continuum of health care delivery. In the center, we look at systems engineering, […]
Tags: anticoagulant, big data, Center for the Science of Health Care Delivery, individualized medicine, OptumLabs, precision medicine